Pages that link to "Item:Q2218815"
From MaRDI portal
The following pages link to Subtleties in the interpretation of hazard contrasts (Q2218815):
Displaying 27 items.
- A generalized theory of separable effects in competing event settings (Q2074081) (← links)
- On the targets of inference with multivariate failure time data (Q2087744) (← links)
- Continuous-time targeted minimum loss-based estimation of intervention-specific mean outcomes (Q2105179) (← links)
- Intention-to-treat comparisons in randomized trials (Q2163074) (← links)
- Longitudinal mediation analysis of time-to-event endpoints in the presence of competing risks (Q2163811) (← links)
- Prevalent cohort studies and unobserved heterogeneity (Q2305790) (← links)
- Maximum Likelihood Estimation in the Additive Hazards Model (Q6055736) (← links)
- On the logic of collapsibility for causal effect measures (Q6068460) (← links)
- Discussion on ‘Correct and logical causal inference for binary and time‐to‐event outcomes in randomized controlled trials' (Q6068461) (← links)
- Discussion on “Instrumental Variable Estimation of the Causal Hazard Ratio,” by Linbo Wang, Eric Tchetgen Tchetgen, Torben Martinussen, and Stijn Vansteelandt (Q6079733) (← links)
- Estimation of separable direct and indirect effects in continuous time (Q6079850) (← links)
- Cox (1972): recollections and reflections (Q6092301) (← links)
- Fifty years with the Cox proportional hazards regression model (Q6149599) (← links)
- On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects (Q6160989) (← links)
- Causal inference with recurrent and competing events (Q6205045) (← links)
- Bias of the additive hazard model in the presence of causal effect heterogeneity (Q6571293) (← links)
- The built-in selection bias of hazard ratios formalized using structural causal models (Q6571294) (← links)
- Multistate models as a framework for estimand specification in clinical trials of complex processes (Q6617493) (← links)
- Causal inference in survival analysis using longitudinal observational data: sequential trials and marginal structural models (Q6625757) (← links)
- Analysis of time-to-event for observational studies: guidance to the use of intensity models (Q6627876) (← links)
- On estimation and cross-validation of dynamic treatment regimes with competing risks (Q6629369) (← links)
- Summarizing causal differences in survival curves in the presence of unmeasured confounding (Q6636021) (← links)
- Estimating population-averaged hazard ratios in the presence of unmeasured confounding (Q6636205) (← links)
- Causal inference for oncology: past developments and current challenges (Q6636227) (← links)
- A robust hazard ratio for general modeling of survival-times (Q6637115) (← links)
- Semiparametric additive modeling of the restricted mean survival time (Q6649333) (← links)
- Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time-to-event endpoints (Q6652628) (← links)
